comments

Pharmacological treatment can be cost-effective

A systematic review of pharmacological treatment in primary care (orlistat, sibutramine and rimonabant– the latter two now withdrawn) has shown all were effective at reducing weight and BMI, and cost effective when using a threshold of £20,000 per QALY.

RELATED ARTICLESExplain
⌅
Tackling obesity in the UK
⌃
Tackling obesity
⌃
Develop a coherent fiscal, regulatory and governance framework
⌃
Invest in weight management services
⌃
Improve support for people with severe and complicated obesity
■
Pharmacological treatment can be cost-effective
□
Develop a patient charter for those with obesity problems
□
Multidisciplinary teams to cover severe and complex obesity across UK
□
Bariatric surgery can be cost effective
□
NICE guidance has been ignored on bariatric services
□
Graph of this discussion
Enter the title of your article


Enter a short (max 500 characters) summation of your article
Enter the main body of your article
Lock
+Comments (0)
+Citations (1)
+About
Enter comment

Select article text to quote
welcome text

First name   Last name 

Email

Skip